Global Retirement Partners, LLC Revance Therapeutics, Inc. Transaction History
Global Retirement Partners, LLC
- $3.4 Billion
- Q4 2024
A detailed history of Global Retirement Partners, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 183 shares of RVNC stock, worth $470. This represents 0.0% of its overall portfolio holdings.
Number of Shares
183Holding current value
$470% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding RVNC
# of Institutions
223Shares Held
81MCall Options Held
680KPut Options Held
896K-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.73MShares$14.7 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.78MShares$12.3 Million0.0% of portfolio
-
Fil LTD Hamilton, D04.19MShares$10.8 Million0.01% of portfolio
-
Alliancebernstein L.P. New York, NY3.26MShares$8.38 Million0.0% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...